Replicel
Collapse
X
-
You're making a classic mistake of assuming a price decline or increase is related to a companies health.Wow. Just checked their stock price. Down to .47 cents. Glad I got outta this POS. This company is dying fast.
http://finance.yahoo.com/q?s=repcf&ql=1
While generally that is true -- it applies moreso to established companies that actually have products on the market. Product-In-Development baby BioTech companies should rarely be viewed the same.Leave a comment:
-
2013/14 big years
I think that when replicel gets this efficacy trial in the books, Mr. ccmethinning will be reaching for the un-send button on his December 29th assertion. Dont think they expected to do much with 20 people and uber-dosing of subjects, except of course to show that if that burrage of cells causes no ill effects, then nothing will. Good luck to 'em, I say.Leave a comment:
-
Wow. Just checked their stock price. Down to .47 cents. Glad I got outta this POS. This company is dying fast.
Leave a comment:
-
-
LMAOThe time is a real issue?
Should I analyze this pic as I did with Histogen? Please say "NO!"
Plz don't! We just have to stay positive and wait for more updates!Leave a comment:
-
The time is a real issue?Same here - the only hope for me is some kind of cell therapy coming out - because I doubt PGD2 will be able to treat a NW5 patient.
Really dissapointed about the start date of Replicel, I'm happy that they've been approved to continue their study but just the time is becoming a real issue now..
Should I analyze this pic as I did with Histogen? Please say "NO!"Leave a comment:
-
Hey guys,
Not sure if anyone has posted this yet. Seems pretty interesting and highlights what Replicel is planning for 2013:
enjoy
Leave a comment:
-
Im really pissed off - this is just snails pace now.
My liver is set for another rough year by the looks of things.Leave a comment:
-
Yeah it sucks. I'm also annoyed they have apparently scratched their 12 month results analysis. Histogen had MUCH better results at 12 months over 6. But we have no way of knowing whether Replicel will too.
It may be an admission that the trial effectively failed, considering also all the extra work they've done tinkering with the process. But who knows.Leave a comment:
-
-
Can you wait until 2017-2018 when a superior treatment will be available? If not, consider a hair transplant.
Sorry, but its the truth.Leave a comment:
-
Same here - the only hope for me is some kind of cell therapy coming out - because I doubt PGD2 will be able to treat a NW5 patient.
Really dissapointed about the start date of Replicel, I'm happy that they've been approved to continue their study but just the time is becoming a real issue now.. I mean how many more years do we need to wait for a better treatment?
UK, you mind if i ask your age? Would you consider a hair transplant?
The waiting around is killing me. And the more results that come out, the further away we seem to a solution. I thought 2012 was going to be the year when we find out for sure what's cooking and whether there is reason to have hope. But, 2012 is nearly up and things are as bleak as ever - replicel looks less than promising, histogen's results numerically look good but photos are not impressive, aderans continues to be a mystery, follica seems to have dropped out, and acell was a total bust. Could use some good news already.Leave a comment:
-
Same here - the only hope for me is some kind of cell therapy coming out - because I doubt PGD2 will be able to treat a NW5 patient.
Really dissapointed about the start date of Replicel, I'm happy that they've been approved to continue their study but just the time is becoming a real issue now.. I mean how many more years do we need to wait for a better treatment?Leave a comment:
Leave a comment: